Index S&P 500 P/E 22.81 EPS (ttm) 7.70 Insider Own 0.52% Shs Outstand 111.00M Perf Week 1.54%
Market Cap 19.48B Forward P/E 16.66 EPS next Y 10.54 Insider Trans -14.87% Shs Float 110.35M Perf Month 6.48%
Income 866.00M PEG 2.66 EPS next Q 2.21 Inst Own 91.41% Short Float 2.68% Perf Quarter 8.41%
Sales 9.87B P/S 1.97 EPS this Y 8.70% Inst Trans 1.47% Short Ratio 2.96 Perf Half Y 12.98%
Book/sh 61.06 P/B 2.88 EPS next Y 8.58% ROA 5.74% Short Interest 2.96M Perf Year 41.00%
Cash/sh 4.95 P/C 35.49 EPS next 5Y 8.56% ROE 13.24% 52W Range 125.09 - 178.09 Perf YTD 16.37%
Dividend Est. 3.03 (1.73%) P/FCF 21.43 EPS past 5Y 4.04% ROI 6.70% 52W High -1.42% Beta 0.78
Dividend TTM 3.00 (1.71%) Quick Ratio 1.02 Sales past 5Y 5.68% Gross Margin 31.87% 52W Low 40.35% ATR (14) 3.58
Dividend Ex-Date Apr 07, 2025 Current Ratio 1.10 EPS Y/Y TTM 2.56% Oper. Margin 14.31% RSI (14) 63.20 Volatility 2.38% 2.00%
Employees 56000 Debt/Eq 1.05 Sales Y/Y TTM 6.70% Profit Margin 8.77% Recom 2.14 Target Price 179.60
Option/Short Yes / Yes LT Debt/Eq 0.91 EPS Q/Q 14.58% Payout 39.15% Rel Volume 1.09 Prev Close 171.67
Sales Surprise 1.65% EPS Surprise 2.02% Sales Q/Q 14.55% Earnings Jan 30 BMO Avg Volume 998.19K Price 175.56
SMA20 2.64% SMA50 8.72% SMA200 14.77% Trades
Volume 1,091,908 Change 2.27%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-04-25 Downgrade Citigroup
Buy → Neutral
$185
Jan-06-25 Upgrade Leerink Partners
Market Perform → Outperform
$169 → $174
Dec-17-24 Upgrade Morgan Stanley
Equal-Weight → Overweight
$145 → $172
Dec-10-24 Resumed Jefferies
Buy
$175 → $185
Oct-23-24 Upgrade Robert W. Baird
Neutral → Outperform
$157 → $182
Aug-28-24 Resumed Evercore ISI
In-line
$165
Jul-10-24 Upgrade Citigroup
Neutral → Buy
$145 → $165
Feb-26-24 Initiated Leerink Partners
Market Perform
$135
Feb-07-24 Upgrade Jefferies
Hold → Buy
$140 → $155
Jan-03-24 Initiated Barclays
Equal Weight
$145
Dec-12-23 Upgrade BofA Securities
Neutral → Buy
$140 → $160
Jun-29-23 Initiated Piper Sandler
Neutral
May-02-23 Downgrade BofA Securities
Buy → Neutral
$166 → $148
Apr-03-23 Upgrade Citigroup
Sell → Neutral
$125 → $142
Jan-23-23 Initiated Evercore ISI
In-line
$159
Nov-17-22 Downgrade Citigroup
Neutral → Sell
$145 → $125
Aug-22-22 Resumed Morgan Stanley
Equal-Weight
$142
Apr-04-22 Downgrade Citigroup
Buy → Neutral
$175 → $140
Feb-23-22 Downgrade UBS
Buy → Neutral
$160 → $139
Feb-02-22 Downgrade Jefferies
Buy → Hold
$135
Show Previous Ratings
Feb-25-25 12:52PM
Feb-24-25 11:21PM
02:35PM
08:00AM
Feb-21-25 02:15AM
04:03AM
Loading…
Feb-20-25 04:03AM
Feb-19-25 04:12PM
12:20PM
10:10AM
Feb-13-25 04:54PM
03:30PM
10:07AM
Feb-12-25 05:57PM
12:50PM
09:00AM
09:50AM
Loading…
Feb-10-25 09:50AM
Feb-04-25 05:29PM
09:40AM
Feb-03-25 02:00PM
09:45AM
Jan-31-25 12:00PM
02:33AM
01:50AM
(Thomson Reuters StreetEvents)
Jan-30-25 05:56PM
(Morningstar Research) +5.62%
04:14PM
04:07PM
07:55AM
07:04AM
(Associated Press Finance)
06:45AM
Jan-28-25 07:04AM
08:56AM
Loading…
Jan-27-25 08:56AM
Jan-24-25 09:40AM
Jan-08-25 01:45PM
08:42AM
Jan-03-25 12:10PM
Jan-02-25 11:15AM
11:00AM
Dec-23-24 12:30PM
Dec-20-24 10:31AM
Dec-19-24 08:01AM
Dec-17-24 03:10PM
Dec-03-24 09:50AM
08:23AM
Nov-28-24 05:30AM
Nov-21-24 11:30AM
Nov-20-24 02:44PM
(Investor's Business Daily)
Nov-13-24 12:00PM
Nov-12-24 05:57PM
Oct-25-24 09:15AM
Oct-24-24 01:06AM
Oct-23-24 07:53AM
03:03AM
Oct-22-24 11:49PM
(Thomson Reuters StreetEvents) +6.85%
05:22PM
03:46PM
07:55AM
06:51AM
(Associated Press Finance)
06:45AM
Oct-16-24 09:40AM
Oct-15-24 10:00AM
08:04AM
Oct-14-24 08:50AM
Sep-30-24 09:40AM
Sep-25-24 11:24AM
Sep-24-24 09:40AM
Sep-18-24 08:51AM
Sep-16-24 08:51AM
Sep-05-24 09:40AM
Aug-30-24 09:40AM
Aug-28-24 03:31PM
Aug-27-24 08:23AM
Aug-26-24 08:50AM
08:31AM
Aug-23-24 07:53AM
Aug-22-24 11:30AM
10:35AM
09:15AM
Aug-21-24 08:55AM
Aug-19-24 08:07AM
Aug-16-24 06:33AM
Aug-15-24 06:13PM
09:05AM
07:32AM
Aug-14-24 07:04PM
09:40AM
Aug-13-24 11:24AM
08:55AM
Aug-12-24 08:51AM
Aug-11-24 07:37AM
Aug-05-24 09:15AM
Aug-01-24 06:48AM
Jul-29-24 09:40AM
08:03AM
Jul-26-24 01:04AM
Jul-25-24 06:45AM
Jul-24-24 07:47AM
03:24AM
12:21AM
(Thomson Reuters StreetEvents)
Jul-23-24 10:05AM
07:55AM
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Doherty Catherine T. EVP, Regional Businesses Mar 05 '25 Sale 174.13 5,370 935,078 68,068 Mar 07 07:23 PM Doherty Catherine T. EVP, Regional Businesses Mar 04 '25 Sale 175.79 716 125,866 68,068 Mar 05 04:38 PM PREVOZNIK MICHAEL E SVP & General Counsel Mar 04 '25 Sale 175.79 592 104,068 38,117 Mar 05 04:35 PM Doherty Catherine T. Officer Mar 05 '25 Proposed Sale 174.13 5,370 935,078 Mar 05 09:59 AM PREVOZNIK MICHAEL E Officer Mar 04 '25 Proposed Sale 175.79 592 104,068 Mar 04 10:20 AM Doherty Catherine T. Officer Mar 04 '25 Proposed Sale 175.79 716 125,866 Mar 04 09:58 AM PREVOZNIK MICHAEL E SVP & General Counsel Feb 27 '25 Sale 172.61 528 91,138 39,031 Feb 28 04:38 PM Doherty Catherine T. EVP, Regional Businesses Feb 27 '25 Sale 172.61 824 142,231 69,178 Feb 28 04:35 PM Doherty Catherine T. Officer Feb 27 '25 Proposed Sale 172.61 824 142,231 Feb 27 10:52 AM PREVOZNIK MICHAEL E Officer Feb 27 '25 Proposed Sale 172.61 528 91,138 Feb 27 10:41 AM PREVOZNIK MICHAEL E SVP & General Counsel Feb 20 '25 Sale 170.99 604 103,278 39,845 Feb 21 04:44 PM Plewman Patrick SVP for Diagnostic Services Feb 19 '25 Sale 169.71 320 54,307 18,082 Feb 21 04:43 PM Doherty Catherine T. EVP, Regional Businesses Feb 20 '25 Sale 170.99 899 153,720 70,457 Feb 21 04:41 PM Doherty Catherine T. EVP, Regional Businesses Feb 19 '25 Sale 169.71 535 90,795 71,356 Feb 21 04:41 PM PREVOZNIK MICHAEL E Officer Feb 20 '25 Proposed Sale 170.99 604 103,278 Feb 20 10:01 AM Doherty Catherine T. Officer Feb 20 '25 Proposed Sale 170.99 899 153,720 Feb 20 09:56 AM Gregg Vicky B Director Feb 05 '25 Sale 164.57 1,250 205,710 16,867 Feb 07 04:37 PM DELANEY MARK E SVP & Chief Commercial Officer Feb 05 '25 Sale 164.30 403 66,214 4,624 Feb 07 04:36 PM DELANEY MARK E Officer Feb 05 '25 Proposed Sale 164.30 403 66,214 Feb 05 05:06 PM Gregg Vicky B Director Feb 05 '25 Proposed Sale 164.57 1,250 205,710 Feb 05 04:00 PM DELANEY MARK E Officer Jan 31 '25 Proposed Sale 164.85 2,615 431,094 Jan 31 01:12 PM PREVOZNIK MICHAEL E SVP & General Counsel Nov 29 '24 Option Exercise 86.63 35,146 3,044,698 73,624 Dec 02 04:43 PM PREVOZNIK MICHAEL E SVP & General Counsel Nov 29 '24 Sale 163.07 35,146 5,731,302 38,478 Dec 02 04:43 PM Doherty Catherine T. EVP, Regional Businesses Nov 27 '24 Option Exercise 103.57 33,103 3,428,478 101,515 Dec 02 04:41 PM Doherty Catherine T. EVP, Regional Businesses Nov 27 '24 Sale 162.99 33,103 5,395,484 68,412 Dec 02 04:41 PM PREVOZNIK MICHAEL E Officer Nov 29 '24 Proposed Sale 163.07 35,146 5,731,302 Nov 29 02:42 PM Doherty Catherine T. Officer Nov 27 '24 Proposed Sale 162.99 33,103 5,395,484 Nov 27 04:12 PM DEPPE MICHAEL J SVP, Corp. Controller & CAO Nov 06 '24 Option Exercise 68.66 18,755 1,287,634 53,696 Nov 07 05:21 PM DEPPE MICHAEL J SVP, Corp. Controller & CAO Nov 06 '24 Sale 154.05 18,755 2,889,123 34,941 Nov 07 05:21 PM KUPPUSAMY KARTHIK SVP, Clinical Solutions Oct 28 '24 Sale 156.92 1,775 278,525 9,734 Oct 30 04:26 PM KUPPUSAMY KARTHIK Officer Oct 28 '24 Proposed Sale 156.87 1,775 278,450 Oct 28 12:51 PM PREVOZNIK MICHAEL E SVP & General Counsel Aug 29 '24 Option Exercise 95.80 32,551 3,118,223 71,029 Sep 03 04:30 PM PREVOZNIK MICHAEL E SVP & General Counsel Aug 29 '24 Sale 154.97 32,551 5,044,516 38,478 Sep 03 04:30 PM KUPPUSAMY KARTHIK SVP, Clinical Solutions Aug 28 '24 Sale 153.26 1,990 304,990 11,459 Aug 29 04:45 PM PREVOZNIK MICHAEL E Officer Aug 29 '24 Proposed Sale 154.97 32,551 5,044,516 Aug 29 01:55 PM KUPPUSAMY KARTHIK Officer Aug 28 '24 Proposed Sale 153.26 1,990 304,990 Aug 28 04:49 PM DELANEY MARK E SVP & Chief Commercial Officer Jul 24 '24 Sale 143.08 420 60,094 5,019 Jul 26 06:33 PM KUPPUSAMY KARTHIK SVP, Clinical Solutions Apr 29 '24 Sale 140.00 1,760 246,400 13,435 May 01 04:26 PM
Index - P/E 11.01 EPS (ttm) 2.78 Insider Own 2.63% Shs Outstand 91.78M Perf Week 1.97%
Market Cap 2.84B Forward P/E 10.06 EPS next Y 3.04 Insider Trans 0.00% Shs Float 90.47M Perf Month -32.07%
Income 255.61M PEG - EPS next Q 0.39 Inst Own 108.36% Short Float 6.36% Perf Quarter -27.64%
Sales 3.15B P/S 0.90 EPS this Y -18.78% Inst Trans 1.65% Short Ratio 3.13 Perf Half Y -61.38%
Book/sh 33.49 P/B 0.91 EPS next Y 13.35% ROA 4.52% Short Interest 5.76M Perf Year -63.92%
Cash/sh 0.82 P/C 37.22 EPS next 5Y -1.36% ROE 8.73% 52W Range 28.09 - 85.96 Perf YTD -22.90%
Dividend Est. - P/FCF - EPS past 5Y 17.49% ROI 5.05% 52W High -64.44% Beta 1.15
Dividend TTM - Quick Ratio 0.99 Sales past 5Y 9.50% Gross Margin 22.57% 52W Low 8.83% ATR (14) 2.10
Dividend Ex-Date - Current Ratio 1.00 EPS Y/Y TTM 1321.36% Oper. Margin 16.56% RSI (14) 27.58 Volatility 7.10% 4.87%
Employees 25500 Debt/Eq 0.68 Sales Y/Y TTM 7.69% Profit Margin 8.10% Recom 1.46 Target Price 48.31
Option/Short Yes / Yes LT Debt/Eq 0.65 EPS Q/Q -43.57% Payout 0.00% Rel Volume 1.81 Prev Close 29.91
Sales Surprise -0.61% EPS Surprise -10.44% Sales Q/Q 4.23% Earnings Feb 27 AMC Avg Volume 1.84M Price 30.57
SMA20 -19.27% SMA50 -25.35% SMA200 -45.48% Trades
Volume 3,323,138 Change 2.21%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-28-25 Downgrade Barclays
Overweight → Equal Weight
$43 → $35
Jan-07-25 Upgrade KeyBanc Capital Markets
Sector Weight → Overweight
$70
Dec-12-24 Upgrade Deutsche Bank
Hold → Buy
$45 → $75
Oct-11-24 Initiated KeyBanc Capital Markets
Sector Weight
Apr-25-24 Upgrade Deutsche Bank
Sell → Hold
$70
Mar-06-24 Initiated Barclays
Overweight
$100
Apr-21-23 Initiated Cantor Fitzgerald
Neutral
$83
Apr-20-23 Downgrade Deutsche Bank
Hold → Sell
$75 → $63
Dec-12-22 Upgrade Loop Capital
Hold → Buy
$90 → $95
Jun-17-22 Initiated Loop Capital
Hold
$72
Sep-27-21 Initiated SVB Leerink
Outperform
$85
Sep-24-21 Initiated UBS
Buy
$81
Sep-20-21 Upgrade Credit Suisse
Neutral → Outperform
$68
Sep-10-21 Initiated Cowen
Outperform
$79
Aug-12-21 Initiated Barclays
Underweight
$69
Jul-09-21 Initiated Seaport Global Securities
Neutral
Nov-17-20 Upgrade UBS
Neutral → Buy
$37 → $54
Sep-30-20 Upgrade Raymond James
Outperform → Strong Buy
$40 → $48
Jan-28-20 Initiated Stephens
Equal-Weight
$36
Dec-11-19 Downgrade Wells Fargo
Outperform → Market Perform
Show Previous Ratings
Mar-06-25 04:05PM
Mar-05-25 07:57AM
Mar-01-25 04:42PM
02:08AM
12:01AM
(Thomson Reuters StreetEvents)
01:49PM
Loading…
Feb-28-25 01:49PM
10:01AM
Feb-27-25 05:25PM
05:06PM
04:43PM
(Associated Press Finance)
04:05PM
02:03PM
Feb-26-25 09:00AM
08:06AM
Feb-21-25 11:00AM
12:03PM
Loading…
Feb-20-25 12:03PM
10:00AM
Feb-14-25 04:10AM
Feb-06-25 11:00AM
Jan-30-25 06:22AM
Jan-27-25 12:10PM
Jan-23-25 06:27AM
Jan-21-25 10:15AM
Jan-07-25 11:00AM
09:29AM
Dec-03-24 08:36AM
Dec-02-24 03:06PM
Nov-29-24 12:36PM
11:31AM
Nov-28-24 10:55AM
07:25AM
Loading…
Nov-26-24 07:25AM
04:36AM
Nov-25-24 02:36PM
Nov-21-24 10:42AM
Nov-20-24 08:55AM
Nov-18-24 03:15PM
Nov-15-24 12:07PM
Nov-13-24 01:35PM
Nov-12-24 11:00AM
Nov-11-24 03:31PM
Nov-07-24 04:55PM
Nov-06-24 03:01PM
Nov-04-24 03:38PM
03:11PM
Nov-01-24 11:23AM
08:52AM
03:08AM
Oct-31-24 11:52AM
Oct-30-24 07:10PM
06:13PM
(Associated Press Finance)
04:18PM
11:50AM
Oct-28-24 10:03AM
Oct-23-24 10:01AM
09:07AM
09:00AM
Oct-22-24 04:31AM
Oct-19-24 03:00PM
Oct-17-24 11:39AM
Oct-16-24 11:07AM
Oct-15-24 12:10PM
08:00AM
Oct-10-24 11:00AM
Oct-06-24 08:09AM
Oct-04-24 09:00PM
Oct-03-24 03:47PM
Oct-01-24 09:55AM
09:35AM
Sep-27-24 04:12PM
03:51PM
10:10AM
08:30AM
Sep-25-24 09:00PM
Sep-16-24 09:00PM
Sep-09-24 04:00PM
(The Wall Street Journal)
10:00AM
Aug-30-24 11:31AM
Aug-28-24 04:15AM
Aug-27-24 02:39PM
Aug-14-24 02:20PM
Aug-05-24 01:26PM
Aug-02-24 12:55AM
(Thomson Reuters StreetEvents)
Jul-31-24 06:25PM
05:22PM
(Associated Press Finance)
04:05PM
Jul-23-24 08:40AM
Jul-16-24 04:01PM
09:00AM
Jun-05-24 10:27AM
May-31-24 11:31AM
May-28-24 12:22PM
May-21-24 11:00AM
May-15-24 09:04AM
May-09-24 11:21AM
May-08-24 04:21AM
May-07-24 02:23PM
11:00AM
May-06-24 12:46PM
May-03-24 03:44PM
03:23AM
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hollinsworth John S. Officer Aug 30 '24 Proposed Sale 53.02 20,000 1,060,339 Aug 30 04:23 PM Hollinsworth John S. Officer Aug 29 '24 Proposed Sale 81.21 10,000 812,065 Aug 29 04:07 PM Hollinsworth John S. Officer Aug 08 '24 Proposed Sale 71.57 5,000 357,829 Aug 08 04:02 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
